VUMC COVID-19 Research Activities


Research continues at VUMC into the causes, treatment and prevention of COVID-19.  See below to learn more about basic/translational, clinical/interventional and population health research now in progress.  

Are you conducting COVID-19 research at Vanderbilt? Please use this brief survey to tell us about your ongoing basic, clinical and/or population sciences research efforts related to SARS-COV-2 and COVID-19:

Research Highlights

December 1, 2020: James Crowe, Jr receives 2020 "Golden Goose" Award for COVID-19 Research

November 9, 2020: JAMA publication shows hydroxychloroquine does not help patients hospitalized with COVID-19

October 26, 2020: COVID treatment studied by VUMC gains FDA approval

September 2, 2020: VUMC joins national network to conduct ACTIV-2 clinical trial of outpatient treatments for COVID-19

August 21, 2020: VUMC awarded $34 million to lead nationwide convalescent plasma study

June 17, 2020: Initial COVID-19 testing data show impact in Nashville’s minority communities

May 14, 2020: The Front Lines: Vanderbilt physicians, researchers join worldwide fight against COVID-19

May 5, 2020, From Science: The race is on for antibodies that stop the new coronavirus

Research conducted at VUMC into the causes, treatment and prevention of COVID-19